As of 2023, the share of corresponding/leading authors in scientific publications in pulmonary and respiratory medicine in China was 98.35%. The forecast from 2024 to 2028 shows a steady increase, with the share rising from 98.43% to 98.75%. This indicates a consistent growth momentum over the period, with a compound annual growth rate (CAGR) of approximately 0.08% per year.
The year-on-year increase is subtle but consistent, suggesting a continued stability in the involvement of leading authors from this region. Future trends to watch for include the potential impact of international collaborations and shifts in research funding, which could influence authorship dynamics in China's scientific community in this field.
